New Medicine - A Comprehensive Information and Consulting Service  
HOME PRODUCTS & SERVICES ORDER/INQUIRY PRESS RELEASES EMPLOYMENT CONTACT US

Volume 1, # 12 - April, 1996

Table of Contents

VOLUME I REVIEW
Oncology Drugs Market Trends 265
  Prices Rise in the USA 265
  Oncology Drug Revenues Grow 265
Regulatory Developments 266
  Acceleration of Oncology Drug Approvals 266
  Less Restrictive Dissemination of Oncology Product Information 266
STATE-OF-THE-ART MANAGEMENT OF CANCER
Esophageal Cancer 266
  Epidemiology Update 266
  Drug Approval 271
    QLT PhotoTherapeutics 271
Colorectal Cancer 273
  Epidemiology Update 273
  Drug Approvals 273
    Zeneca 274
    Rhône-Poulenc Rorer 274
MECHANISMS IN MALIGNANCY
Apoptosis 274
  New Findings 274
    Apoptosis Technology 274
  Apoptosis Mediating Drugs in Development 274
    Milkhaus Laboratory 274
Angiogenesis 274
  Angiogenesis in the Assessment of Cancer 274
  Angiogenesis-based Therapeutics 275
    Angiogenesis Technologies 275
    EntreMed 275
    Texas Biotechnology 275
  Other Developments 275
ANTICANCER DRUGS AND MARKETS
Taxanes 275
  Paclitaxel 275
  Docetaxel 276
Platinum-based Drugs 276
  JM-216 276
TECHNOLOGY UPDATE
Radiopharmaceuticals in Cancer Diagnosis 276
  USA Markets 276
    Market estimates and forecasts 276
    Distribution trends 276
    Pricing trends 276
  Agents Approved, Recommended or in Development for Cancer Imaging 276
    Antisoma 277
    Biomira 277
    Cytogen 277
    Diatide 278
    DuPont Merck Pharmaceutical 278
    Immunomedics 278
    Neoprobe 278
    NeoRx 279
    Nycomed Imaging 279
    Resolution Pharmaceuticals 279
    Syncor International 276

HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US

NEW MEDICINE, INC.
PHONE: 949-830-0448   FAX: 949-830-0887